4.5 Article

miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p

Related references

Note: Only part of the references are listed.
Article Oncology

miR-137 downregulates c-kit expression in acute myeloid leukemia

Yanping Hu et al.

LEUKEMIA RESEARCH (2017)

Article Medical Laboratory Technology

Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia

Ting-juan Zhang et al.

CLINICAL LABORATORY (2016)

Article Biochemistry & Molecular Biology

miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis

Chunyue Weng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Letter Oncology

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia

K. Krowiorz et al.

BLOOD CANCER JOURNAL (2016)

Article Multidisciplinary Sciences

Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia

Erwin M. Schoof et al.

DATA IN BRIEF (2016)

Article Biochemistry & Molecular Biology

miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway

Liang Zhao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

Elisabetta Crippa et al.

PLOS ONE (2014)

Article Cell Biology

SnapShot: Acute Myeloid Leukemia

Bernd B. Zeisig et al.

CANCER CELL (2012)

Article Oncology

Roles of Arrest-Defective Protein 1225 and Hypoxia-Inducible Factor 1α in Tumor Growth and Metastasis

Mi-Ni Lee et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Biochemistry & Molecular Biology

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

Hsu-Ping Kuo et al.

SCIENCE SIGNALING (2010)

Article Oncology

Cancer statistics, 2008

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2008)

Review Oncology

The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?

Thomas Arnesen et al.

CURRENT CANCER DRUG TARGETS (2008)